Department of Pathology

Medicine & Life Sciences

1. Neoplasms 100%
2. Hepatocellular Carcinoma 80%
3. Urinary Bladder Neoplasms 48%
4. Hepatitis B virus 44%
5. Liver 42%
6. Carcinoma 39%
7. Colorectal Neoplasms 37%
8. Carcinogenesis 37%
9. Transitional Cell Carcinoma 35%
10. Survival 33%
11. ErbB Receptors 33%
12. Lymphoma, Large B-Cell, Diffuse 33%
13. Chronic Hepatitis B 32%
14. T-Cell Lymphoma 27%
15. Helicobacter pylori 25%
16. Urinary Bladder 25%
17. Mutation 24%
18. Serum 22%
19. Therapeutics 22%
20. Membrane Proteins 22%
21. Growth 20%
22. Genes 20%
23. Lymphoma 19%
24. Urinary Tract 18%
25. Metaplasia 17%
26. rice bran saccharide 17%
27. Urine 17%
28. Drug Therapy 17%
29. Stomach 16%
30. Nasopharyngeal Carcinoma 16%
31. Non-Small Cell Lung Carcinoma 16%
32. Pylorus 16%
33. Endoplasmic Reticulum Stress 15%
34. DNA 15%
35. Adenocarcinoma 15%
36. Biomarkers 15%
37. Proteins 15%
38. Cell Line 15%
39. Vascular Endothelial Growth Factor A 14%
40. Squamous Cell Carcinoma 14%
41. Staining and Labeling 14%
42. Methotrexate 13%
43. Hepatitis B Surface Antigens 13%
44. Oncogene Proteins 12%
45. Glass 12%
46. Biopsy 12%
47. Microsatellite Repeats 12%
48. B-Lymphocytes 12%
49. Inflammation 12%
50. spasmolytic polypeptide 12%
51. In Vitro Techniques 12%
52. Osteopontin 12%
53. Electromagnetic Phenomena 12%
54. Immunoglobulin G 12%
55. Pancreatic Neoplasms 12%
56. Loss of Heterozygosity 11%
57. Isoflavones 11%
58. Surface Antigens 11%
59. Lymphocytes 11%
60. Stomach Neoplasms 11%
61. Immunohistochemistry 11%
62. Lung 11%
63. Peripherins 11%
64. Hemophagocytic Lymphohistiocytosis 11%
65. Pterygium 11%
66. T-Lymphocytes 11%
67. interleukin 20 11%
68. Cell Proliferation 11%
69. Hepatitis B e Antigens 11%
70. Hydroa Vacciniforme 10%
71. TOR Serine-Threonine Kinases 10%
72. tissue polypeptide specific antigen 10%
73. Cytogenetics 10%
74. Lymphadenopathy 10%
75. Skin 10%
76. Gastrointestinal Stromal Tumors 10%
77. Epidermal Growth Factor 10%
78. Mouth Neoplasms 10%
79. Verrucous Carcinoma 10%
80. Adenoma 9%
81. Macrophages 9%
82. Thymic epithelial tumor 9%
83. Genotype 9%
84. Multivariate Analysis 9%
85. Phosphotransferases 9%
86. Intermediate Filament Proteins 9%
87. Down-Regulation 9%